PER
Click for more information
2.50% 8.2¢ percheron therapeutics limited

As part of its Type C meeting, the Company is requesting that...

  1. Akki
    35,748 Posts.
    lightbulb Created with Sketch. 554
    clock Created with Sketch.
    23/04/21
    11:55
    Post #: 52676675
    As part of its Type C meeting, the Company is requesting that the FDA consider allowing the data from previously conducted 6-month monkey toxicity studies, and recently obtained 6-month (24 weeks of dosing) clinical safety data in non-ambulant DMD patients, to support the longer term (12-month) dosing of ATL1102 in DMD patients in the US.
    ANP Price at posting: 21.5¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TPG ACCC says no issue with TPG Telecom and Optus Mobile sharing regional networks; spectrum
right-arrow Created with Sketch.
SXG Southern Cross finds large gold-antimony zone underneath historic Victorian mine
right-arrow Created with Sketch.
STX Strike hits "significant" 28m of net gas pay downhole Australia's deepest ever gas well; extends system east
right-arrow Created with Sketch.
NEWS ASX explains: How 'futures' are predicted
right-arrow Created with Sketch.
WGX Mining start at South Junction adds to Westgold's hopes for WA gold complex
right-arrow Created with Sketch.
NEWS Is the ASX getting its groove back? Here's 5 IPOs in September to watch
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.2¢ 		Change
0.002(2.50%) 		Mkt cap ! $73.92M
Open High Low Value Volume
8.0¢ 8.2¢ 7.9¢ $16.80K 210.0K

Buyers (Bids)

No. Vol. Price($)
1 24999 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 31992 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.